The role and limitations of 18-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) scan and Computerized Tomography (CT) in restaging patients with hepatic colorectal metastases following neoadjuvant chemotherapy: Comparison with operative and pathological findings

Journal of Gastrointestinal Surgery

Volumn 11, Issue 4, 2007, Pages 472-478

  Lubezky, Nir ^a   Metser, Ur ^a   Geva, Ravit ^a   Nakache, Richard ^a   Shmueli, Einat ^a   Klausner, Joseph M ^a   Even Sapir, Einat ^a   Figer, Arie ^a   Ben Haim, Menahem ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Colorectal liver metastases; FDG PET; Neoadjuvant chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADJUVANT THERAPY; AGED; ARTICLE; COLORECTAL TUMOR; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LIVER RESECTION; LIVER TUMOR; MALE; METASTASIS; MIDDLE AGED; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34250637909     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-006-0032-8     Document Type: Article

References (23)

1. Kemeny N, Fong Y. Treatment of liver metastases. Cancer Medicine. Baltimore: Williams and Wilkins, 1997, pp 1939-1954.
2. Fortner JG, Silva JS, Golbey RB, et al, Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. 1. Treatment by hepatic resection. Ann Surg 1984;199:306-316.
3. Adson MA, Van Heerden JA, Adson MH, et al. Resection of hepatic metastases from colorectal cancer. Arch Surg 1984;11:647-651.
4. Hughes KS, Simon R, Soughourabodi S, et al. Resection of the liver for colorectal carcinoma metastases: a multi institutional study of patterns of recurrence. Surgery 1986;100:278-284.
5. Scheele J, Strangl R, Altendorf-Hofmann A, et al. Resection of colorectal liver metastases. World J Surg 1985;19:59-71.
6. Scheele J, Strangl R, Altendorf-Hofmann A, et al. Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 1991;11:13-29.
7. Gibbs JF, Weber TK, Rodriguez-Bigas MA, et al. Intraoperative determinants of unresectability for patients with colorectal hepatic metastases. Cancer 1982;82:1244-1249.
8. Steele G, Bleday R, Mayer RJ. A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: gastrointestinal tumor study group protocol 6584. J Clin Oncol 1991;9:1105-1112.
9. Valk PE, Abella-Columna E, Haesman MK, et al. Whole body PET imaging with [18F]fluorodeoxyglucose in management of recurrent colorectal cancer. Arch Surg 1999;134:503-511.
10. Delbeke D, Vitola JV, Sandier MP, et al. Staging recurrent metastatic colorectal carcinoma with PET. J Nucl Med 1997;38:1196-1201.
11. Abdel-Nabi H, Doerr RJ, Lamonica DM, et al. Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole body PET: correlation with histopathologic and CT findings. Radiology 1998;206:755-760.
12. Vitola JV, Delbeke D, Sandier MP, et al. PET to stage suspected metastatic colorectal carcinoma to the liver. Am J Surg 1996;171:21-26.
13. Flamen P, Stroobants S, Van-Cutsem E, et al. Additional value of whole-body PET with fluorine-18-2fluoro-2-deoxy-D-glucose in recurrent colorectal cancer. J Clin Oncol 1999;17:894-901.
14. Fernandez F, Drebin JA, Linehan DC, et al. Five year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with 18-f fluorodeoxyglucose (FDG-PET). Ann Surg 2004;240:438-450.
15. Bismuth H, Adam R, Levi F, et al. Resection of nonresectable liver metastasis from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996;224:509-522.
16. Adam R. Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases. Ann Oncol 2003;14 (Suppl 2):ii13-ii16.
17. Tanaka K, Adam R, Shimada H, et al. Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver. Br J Surg 2003;90:963-969.
18. Allen PJ, Kemeny N, Jamagin W, et al. Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. J Gastrointest Surg 2003;7:109-117.
19. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer. Ann Surg 1999;230;309-321.
20. Ruers TJM, Langenhoff BS, Neelman N, et al. Value of positron emission tomography with [f-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study. J Clin Oncol 2002;20:388-395.
21. Kostakoglu L, Goldsmith SJ. 18F-FDG PET evaluation of the response to therapy for lymphoma and for breast, lung, and colorectal carcinoma. J Nucl Med 2003;44:224-239.
22. Whitford MH, Yee LF, Ogunbiyi OA, et al. Usefulness of FDG-PET scan in the assessment of suspected metastases or recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum 2000;43:759-767.
23. Nguyen M, Varma V, Perez R, et al. CT with histopathologic correlation of FDG uptake in a patient with pulmonary granuloma and pleural plaque caused by remote talc pleurodesis. AJR Am J Roentgenol 2004;182:92-94.